Importance of drinking microfiltered raw immune-milk from cows immunized against SARS-CoV-2 in providing short-term protection against COVID-19
COVID-19 is the infectious disease caused by the novel coronavirus SARS-CoV-2, which causes severe respiratory tract infections in humans, has become a global health concern. Currently, all the effort used to prevent the spread of this virus is not sufficient. Many options are being investigated to treat COVID-19 and the transfusion of convalescent plasma or immunoglobulins (Ig), also known as passive immunization, is one of the alternative treatment options.
Fig. 1. Schematic overview of how drinking microfiltered raw immune-milk from cows immunized against SARS-CoV-2 can provide short-term protection against COVID-19.
The passive immunity is a process in which neutralizing immunoglobulins against pathogens collected from recovered individuals can be used to protect or treat the new infected patients. Several vaccine candidates against SARS-CoV-2 are in clinical trials but approval of these vaccines is likely to take a long time before public use. It is well-known that bovine colostrum and cow’s milk are highly rich in IgG1 that binds to many pathogens that infect humans, supporting cross‐species activity between bovine and human immunoglobulins. The microfiltration process eliminates from the milk all pathogens without denaturation of proteins or nutritional changes that could be caused by ultra-high temperature pasteurization of milk. Cow’s milk is accessible to the whole population and consumption of microfiltered raw immune-milk from cows vaccinated against SARS-CoV-2 could provide individuals with short-term protection against this new coronavirus, as an option until vaccines become commercially available.
Samir Jawhara
CNRS, UMR 8576 – UGSF – Unité de Glycobiologie Structurale et Fonctionnelle, INSERM U1285,University of Lille F-59000 Lille, France
Publication
Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?
Samir Jawhara
Front Immunol. 2020 Jul 28
Related Articles:
 | T-cell subsets in HIV infection The human immunodeficiency virus (HIV) is a virus that assaults the body's immunologic system. If HIV is not tackled, it can eventually drive the organism to AIDS, which a dreadful… |
 | No adverse outcomes for infants associated with mums… What is whooping cough, or pertussis? Whooping cough, or pertussis, is a highly contagious bacterial respiratory infection that can be very serious for young infants. Symptoms include violent coughing fits… |
 | Carbapenem-resistant Enterobacteriaceae: fighting mutants Antibiotic resistance occurs when bacteria causing an infection survive after being exposed to a drug that, under normal conditions, would kill it or inhibit its growth. As a result, this… |
 | Clinically utilized nalfurafine combined with… Alcohol addiction poses massive public health costs [~15 million adult alcoholics with economic cost > $200 billion/year in the US]. Pharmacological studies in rodents have demonstrated that kappa-opioid receptor (KOR)… |
 | Campylobacter antimicrobial resistance in dogs and humans Campylobacteriosis has been the most frequently reported zoonotic disease in humans in Europe since 2005, and the annual number of notified campylobacteriosis cases has increased in many European countries in… |
 | BioID screen for bacterial virulence proteins: new… The discovery of penicillin in the 1920s revolutionized our ability to treat bacterial infection. However despite the introduction of antibiotics, infectious bacterial pathogens remain an immense challenge for the healthcare… |
Leave a Reply
You must be logged in to post a comment.